Immunogenicity 14868
Sample ID
3903
Response
Negative
Tumor Type
Melanoma
Gene Symbol
NDRG2
Transcript ID
uc010tll.2
HLA INFO
A*02:01
TCR INFO
No TCR info found!
Full length protein sequence (367 aa)
MENGG
1
SMQAT
6
MAELQ
11
EVQIT
16
EEKPL
21
LPGQT
26
PEAAK
31
THSVE
36
TPYGS
41
VTFTV
46
YGTPK
51
PKRPA
56
ILTYH
61
DVGLN
66
YKSCF
71
QPLFQ
76
FEDMQ
81
EIIQN
86
FVRVH
91
VDAPG
96
MEEGA
101
PVFPL
106
GYQYP
111
SLDQL
116
ADMIP
121
CVLQY
126
LNFST
131
IIGVG
136
VGAGA
141
YILAR
146
YALNH
151
PDTVE
156
GLVLI
161
NIDPN
166
AKGWM
171
DWAAH
176
KLTGL
181
TSSIP
186
EMILG
191
HLFSQ
196
EELSG
201
NSELI
206
QKYRN
211
IITHA
216
PNLDN
221
IELYW
226
NSYNN
231
RRDLN
236
FERGG
241
DITLR
246
CPVML
251
VVGDQ
256
APHED
261
AVVEC
266
NSKLD
271
PTQTS
276
FLKMA
281
DSGGQ
286
PQLTQ
291
PGKLT
296
EAFKY
301
FLQGM
306
GYMAS
311
SCMTR
316
LSRSR
321
TASLT
326
SAASV
331
DGNRS
336
RSRTL
341
SQSSE
346
SGTLS
351
SGPPG
356
HTMEV
361
SC
366
Mutation Information
DNA mutation:
None
Peptide Range:
322 ~ 346
Mut AA position:
None (None in Wild Type peptide)
Alignment
Wild Type:
"SRSRTASLTSAASVDGNRSRSRTLS
||||||||||||.||||||||||||
Mutant:
SRSRTASLTSAAFVDGNRSRSRTLS"
Nat Med, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsGene Name (from Reference) NDRG2
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
PBMCs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay